Overview of Link Between Inflammatory Bowel Disease and Cardiovascular Disease.

Development of NASH in Obese Mice is Confounded by Adipose Tissue Increase in Inflammatory NOV and Oxidative Stress.

Novel Oral Anticoagulants in the Peri-Endoscopic Period.

Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.

Hepatitis C Virus and Nonliver Solid Cancers: Is There an Association between HCV and Cancers of the Pancreas, Thyroid, Kidney, Oral Cavity, Breast, Lung, and Gastrointestinal Tract?

Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.

Screening, diagnosis, treatment, and management of hepatitis C: a novel, comprehensive, online resource center for primary care providers and specialists.

Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.

Clinical significance of discordant positive hepatitis C virus transcription-mediated amplification following end of treatment response.

Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.

Racial differences in hepatitis C treatment eligibility.

Telaprevir for previously untreated chronic hepatitis C virus infection.

Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate.

A report of gastric fundic gland polyps.

Mycophenolate mofetil for autoimmune hepatitis: a single practice experience.